RecruitingNot ApplicableNCT05470920
Genetic Testing Decision Aid
Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes
Sponsor
Massachusetts General Hospital
Enrollment
350 participants
Start Date
Oct 14, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- years or older
- Being seen in clinic at Massachusetts General Hospital or Boston Medical Center
- Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.
Exclusion Criteria4
- Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study
- Previous germline genetic testing
- History of hereditary pancreatitis
- Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults
Interventions
BEHAVIORALElectronic Decision Aid
Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires
BEHAVIORALPre-Test Genetic Counseling
Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05470920
Related Trials
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
NCT072829121 location
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
NCT053765922 locations
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT039772331 location
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
NCT072629571 location
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
NCT070432701 location